Cas:876316-31-3 1-[(2-iodophenyl)methyl]-1,2,4-triazole manufacturer & supplier

We serve Chemical Name:1-[(2-iodophenyl)methyl]-1,2,4-triazole CAS:876316-31-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-[(2-iodophenyl)methyl]-1,2,4-triazole

Chemical Name:1-[(2-iodophenyl)methyl]-1,2,4-triazole
CAS.NO:876316-31-3
Synonyms:1-[(2-iodophenyl)methyl]-1,2,4-triazole
Molecular Formula:C9H8IN3
Molecular Weight:285.08400
HS Code:

Physical and Chemical Properties:
Melting point:67-69.5ºC
Boiling point:400.3ºC at 760 mmHg
Density:1.8g/cm3
Index of Refraction:1.707
PSA:30.71000
Exact Mass:284.97600
LogP:1.93100

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-[(2-iodophenyl)methyl]-1,2,4-triazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[(2-iodophenyl)methyl]-1,2,4-triazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[(2-iodophenyl)methyl]-1,2,4-triazole Use and application,1-[(2-iodophenyl)methyl]-1,2,4-triazole technical grade,usp/ep/jp grade.


Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 1-[(2-iodophenyl)methyl]-1,2,4-triazole manufacturer AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer. 1-[(2-iodophenyl)methyl]-1,2,4-triazole supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 1-[(2-iodophenyl)methyl]-1,2,4-triazole vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. 1-[(2-iodophenyl)methyl]-1,2,4-triazole factory A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns.